Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 31 DECEMBER 2015

Age Of Transparency

Fox Rothschild LLP
Fox Rothschild LLP
Contributor
Explore more from Fox Rothschild LLP

Mark G. McCreary was featured in the Crain's New York Business article, "Age of Transparency." Full text can be found in the December 18, 2015, issue, but a synopsis is below.

United StatesCorporate/Commercial Law
Crain'S New York Business
Crain'S New York Business
Author LinkedIn connections

Mark G. McCreary was featured in the Crain's New York Business article, "Age of Transparency." Full text can be found in the December 18, 2015, issue, but a synopsis is below.

Companies are facing additional pressure for the implementation of strategies to display openness as the demand for transparency rises. General Counsels are now facing new challenges on managing and disclosing information to the government and public as companies seek to prove that they have nothing to hide.

As companies' relationship with consumers becomes more digital in nature, there are certain disclosures they'll need to make, said Mark McCreary, chief privacy officer at Fox Rothschild. "It's not just an IT function. It's really become more of a legal function," he added.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP